Vertex Pharmaceuticals VRTX Peer Comparison

NASDAQ VRTX
$555.47 -2.49 (-0.45%)
As of: Sep 4, 2026 · 9:47 AM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

Vertex Pharmaceuticals Inc / Ma (VRTX) is the 3rd largest of 300 Biotechnology companies by market capitalisation, at 141.03 Bn, behind Gilead Sciences, Inc. at 187.22 Bn. It trades on a P/E of 32.01, 103% above the peer median of 15.81. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 237.61 Bn 0.00 Mn 6.24 223.62 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 187.22 Bn 0.00 Mn 6.15 184.04 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 141.03 Bn 0.00 Mn 11.20 133.18 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 86.23 Bn 0.00 Mn 5.55 78.23 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 64.04 Bn 0.00 Mn 12.25 58.85 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 57.59 Bn 0.00 Mn 25.85 52.45 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 34.97 Bn 0.00 Mn 7.28 31.66 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 32.91 Bn 0.00 Mn 3.28 31.63 Bn
9 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.81 Bn 0.00 Mn 24.45 26.65 Bn
10 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 24.91 Bn 0.00 Mn 8.05 11.25 Bn
11 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 24.76 Bn 0.00 Mn 2,266.66 24.76 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 16.17 Bn 0.00 Mn 13.25 15.23 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.65 Bn 0.00 Mn 12.19 14.82 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.70 Bn 0.00 Mn 20.61 13.98 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.46 Bn — — 12.77 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.90 Bn 0.00 Mn 7.75 12.67 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.77 Bn 0.00 Mn 3.75 11.89 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.33 Bn 0.00 Mn 18.42 10.73 Bn
19 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.28 Bn 0.00 Mn — 9.52 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
21 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.71 Bn 0.00 Mn 34.43 9.71 Bn
22 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.57 Bn 0.00 Mn 10.95 7.52 Bn
23 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.73 Bn 0.00 Mn — 8.73 Bn
24 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.54 Bn 0.00 Mn 51.49 8.18 Bn
25 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.04 Bn 0.00 Mn — 8.04 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn 0.00 Mn 9.97 7.29 Bn
27 ABVX Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.92 Bn 0.00 Mn — 7.92 Bn
28 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.39 Bn 0.00 Mn — 7.39 Bn
29 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.23 Bn 0.00 Mn — 7.23 Bn
30 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.11 Bn 0.00 Mn 29.65 6.78 Bn
31 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.71 Bn 0.00 Mn 4,817.20 6.71 Bn
32 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.51 Bn 0.00 Mn 1,046.07 6.51 Bn
33 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.39 Bn 0.00 Mn 10.34 5.95 Bn
34 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 6.18 Bn 0.00 Mn 7.35 5.65 Bn
35 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.01 Bn 0.00 Mn — 6.01 Bn
36 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.93 Bn 0.00 Mn — 5.93 Bn
37 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.91 Bn 0.00 Mn 5.86 3.69 Bn
38 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.85 Bn — — 4.12 Bn
39 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.81 Bn 0.00 Mn 1,156.61 5.63 Bn
40 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 0.00 Mn 19.97 4.44 Bn
41 GRFS Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 5.32 Bn 0.00 Mn 0.32 4.16 Bn
42 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.29 Bn 0.00 Mn — 5.29 Bn
43 RADX Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 5.08 Bn 0.00 Mn 20,980.03 5.08 Bn
44 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.02 Bn 0.00 Mn — 5.02 Bn
45 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.20 Bn 0.00 Mn 1,165.78 4.20 Bn
46 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.09 Bn — — 3.68 Bn
47 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn 0.00 Mn — 4.06 Bn
48 TLX Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn — — 3.72 Bn
49 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.94 Bn 0.00 Mn — 3.94 Bn
50 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.88 Bn 0.00 Mn 374.54 3.88 Bn
51 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.78 Bn 0.00 Mn — 3.78 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.75 Bn 0.00 Mn 32.09 3.05 Bn
53 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.68 Bn 0.00 Mn 15.71 2.85 Bn
54 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.52 Bn 0.00 Mn 53.19 3.52 Bn
55 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.39 Bn 0.00 Mn 63.06 2.38 Bn
56 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 0.00 Mn 6.70 2.87 Bn
57 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.06 Bn 0.00 Mn — 3.06 Bn
58 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.06 Bn 0.00 Mn 593.06 2.54 Bn
59 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn 0.00 Mn 19,287.57 3.05 Bn
60 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn 0.00 Mn — 2.94 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn 0.00 Mn 6.46 2.20 Bn
62 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.84 Bn 0.00 Mn 77.27 2.40 Bn
63 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.62 Bn 0.00 Mn — 2.62 Bn
64 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.57 Bn 0.00 Mn 4.80 2.21 Bn
65 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.52 Bn 0.00 Mn — 2.52 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.47 Bn 0.00 Mn 45.24 1.79 Bn
67 HCM HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 0.00 Mn 3.41 2.43 Bn
68 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 0.00 Mn 33.85 2.41 Bn
69 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn 0.00 Mn 46.07 2.40 Bn
70 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.32 Bn 0.00 Mn — 2.05 Bn
71 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn 0.00 Mn 12.04 2.16 Bn
72 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.26 Bn 0.00 Mn 113.18 2.26 Bn
73 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn 0.00 Mn — 2.25 Bn
74 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.20 Bn 0.00 Mn — 2.20 Bn
75 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.20 Bn 0.00 Mn 0.35 0.70 Bn
76 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 0.00 Mn 58.58 1.90 Bn
77 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.00 Mn 4.22 2.03 Bn
78 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.00 Mn 2,097.22 2.10 Bn
79 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.00 Mn — 1.72 Bn
80 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn 0.00 Mn 20.19 1.99 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 18.77 1.59 Bn
82 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn 0.00 Mn 70.96 1.66 Bn
83 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.91 Bn 0.00 Mn 34.90 1.36 Bn
84 LKFT Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.91 Bn 0.00 Mn 1.65 1.91 Bn
85 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.91 Bn 0.00 Mn 1,466.74 1.91 Bn
86 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn 0.00 Mn 6.27 1.90 Bn
87 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn 0.00 Mn 4.39 1.01 Bn
88 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.85 Bn 0.00 Mn 7.33 1.30 Bn
89 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.81 Bn 0.00 Mn 1,052.13 1.81 Bn
90 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn 0.00 Mn — 1.80 Bn
91 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn 0.00 Mn 4.20 1.02 Bn
92 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 Mn — 1.37 Bn
93 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn 0.00 Mn — 1.16 Bn
94 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.69 Bn 0.00 Mn 17.11 1.69 Bn
95 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn 0.00 Mn 8.36 1.38 Bn
96 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn 0.00 Mn — 1.66 Bn
97 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn 0.00 Mn 2.24 1.32 Bn
98 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn 0.00 Mn 526.62 1.60 Bn
99 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn 20.12 1.30 Bn
100 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
101 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn — 1.57 Bn
102 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 0.00 Mn — 1.55 Bn
103 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn 0.00 Mn 77.14 1.54 Bn
104 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn 0.00 Mn — 1.47 Bn
105 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn 0.00 Mn — 1.47 Bn
106 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn 0.00 Mn 175.06 0.95 Bn
107 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn 0.00 Mn 50.18 0.81 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 0.00 Mn 896.81 1.20 Bn
109 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn 35.82 1.38 Bn
110 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn — 1.37 Bn
111 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
112 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn 0.00 Mn — 1.36 Bn
113 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn 0.00 Mn — 1.13 Bn
114 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn 0.00 Mn — 1.33 Bn
115 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn 0.00 Mn 51.84 1.24 Bn
116 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn 0.00 Mn 3.10 1.11 Bn
117 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn 0.00 Mn — 1.22 Bn
118 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn 0.00 Mn — 1.14 Bn
119 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.11 Bn 0.00 Mn — 0.57 Bn
120 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 0.00 Mn — 1.05 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 0.00 Mn — 0.96 Bn
122 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 5.56 0.92 Bn
123 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 4.14 0.71 Bn
124 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn 0.00 Mn — 0.97 Bn
125 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn 0.00 Mn 14.67 0.59 Bn
126 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn 0.00 Mn 2.05 0.64 Bn
127 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 0.00 Mn 3.22 0.80 Bn
128 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 8.47 0.50 Bn
129 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 878.61 0.88 Bn
130 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn 0.00 Mn 103.68 0.85 Bn
131 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.83 Bn 0.00 Mn — 0.83 Bn
132 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn 43.30 0.46 Bn
133 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn 0.00 Mn 2.31 0.61 Bn
134 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 0.00 Mn — 0.74 Bn
135 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 0.00 Mn 1.83 0.63 Bn
136 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 0.00 Mn — 0.64 Bn
137 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn — 0.48 Bn
138 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1,132.91 0.62 Bn
139 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 0.00 Mn 9.01 0.35 Bn
140 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 0.00 Mn — 0.65 Bn
141 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -0.37 Mn — 0.36 Bn
142 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn 0.00 Mn 600.07 0.45 Bn
143 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn — 0.61 Bn
144 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn 0.00 Mn 1.90 0.03 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn 0.00 Mn 15.51 0.54 Bn
146 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 554.26 Mn 3.49 0.44 Bn
147 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 0.00 Mn — 0.57 Bn
148 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 0.00 Mn — 0.56 Bn
149 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn 0.00 Mn — 0.54 Bn
150 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn 0.00 Mn 23.04 0.24 Bn
151 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn 9.14 0.21 Bn
152 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn — 0.49 Bn
153 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 13.89 0.23 Bn
154 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn 2.53 0.41 Bn
155 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn 2.08 0.39 Bn
156 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn 78.36 0.24 Bn
157 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.24 Bn
158 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn — 0.45 Bn
159 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn — 0.46 Bn
160 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn — 0.46 Bn
161 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 15.25 0.26 Bn
162 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 44.10 0.24 Bn
163 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn — 0.44 Bn
164 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn 41.27 0.43 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.24 0.22 Bn
166 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
167 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn 142.58 0.22 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn 0.00 Mn — 0.37 Bn
170 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 107.13 0.34 Bn
171 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 9.13 0.27 Bn
172 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn — 0.33 Bn
173 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 2.51 0.33 Bn
174 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 3.67 0.17 Bn
175 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 64.29 0.30 Bn
176 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.88 0.30 Bn
177 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
178 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
179 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn — 0.29 Bn
180 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn — 0.18 Bn
181 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 13.10 0.29 Bn
182 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn — 0.29 Bn
183 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 20.18 0.11 Bn
184 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
185 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 1.61 0.16 Bn
186 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.27 Bn
187 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.14 Bn
188 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 4.56 0.10 Bn
189 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 60.93 0.26 Bn
190 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 22.29 0.26 Bn
191 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
192 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
193 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 3.28 0.16 Bn
194 YDES YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 287.04 0.24 Bn
195 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 17.18 0.21 Bn
196 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
197 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
198 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 10.29 0.08 Bn
199 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 6.71 -0.04 Bn
200 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
201 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
202 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 4.22 0.11 Bn
203 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 32.66 0.21 Bn
204 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.64 0.17 Bn
205 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 88.46 0.10 Bn
206 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn 2.71 -0.02 Bn
207 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
208 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.18 Bn
209 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
210 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn — 0.19 Bn
211 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn 60.95 0.19 Bn
212 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 2.79 0.04 Bn
213 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn — 0.00 Bn
214 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 7.65 0.15 Bn
215 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn — — 0.00 Bn
216 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn — 0.17 Bn
217 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 28.43 0.16 Bn
218 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 32.89 0.16 Bn
219 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 12.75 0.12 Bn
220 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn — 0.14 Bn
221 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 1,869.33 -0.04 Bn
222 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
223 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
224 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
225 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn 1,357.98 0.14 Bn
226 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn — 0.13 Bn
227 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn — 0.13 Bn
228 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 133.04 0.13 Bn
229 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 37.69 0.10 Bn
230 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn 42.16 0.12 Bn
231 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.01 Bn
232 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.06 Bn
233 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.11 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
235 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
236 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn 13.48 0.06 Bn
237 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.10 Bn
238 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
239 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
240 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 138.67 0.09 Bn
241 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
242 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
243 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
244 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
245 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
246 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
247 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 1.25 -0.11 Bn
248 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn 55.22 0.08 Bn
249 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.06 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
251 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
252 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
253 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.06 Bn
254 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 125.51 0.07 Bn
255 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
256 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 1.48 0.02 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
258 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 17.08 0.03 Bn
259 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 3.32 -0.05 Bn
260 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 0.42 0.02 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn — 0.06 Bn
262 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 29.07 0.05 Bn
263 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 5.23 0.00 Bn
264 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 1,478.69 0.05 Bn
265 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
266 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 3.90 0.05 Bn
267 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 294.15 -0.01 Bn
268 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
269 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.02 Bn
270 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 2.18 0.05 Bn
271 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 335.26 0.02 Bn
272 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 86.66 0.04 Bn
273 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
274 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
275 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
276 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 4.72 0.04 Bn
277 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
278 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.03 Bn
279 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 4.54 0.06 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
281 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.93 0.02 Bn
282 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.94 0.03 Bn
283 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
284 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.35 0.03 Bn
285 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
286 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 38.55 0.03 Bn
287 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 93.50 0.03 Bn
288 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
289 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
290 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
291 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
292 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
293 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
294 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 755.61 0.02 Bn
295 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 239.09 0.02 Bn
296 CNSY Cerenome, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.86 0.01 Bn
297 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 2.69 0.02 Bn
298 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
299 KTTA Pasithea Therapeutics Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
300 DYAI Dyadic International Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.90 0.02 Bn